[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  Tourmaline Bio, Inc. Common Stock (TRML) Novartis to acquire Tourmaline Bio for $XX per share, causing the stock to surge to a 52-week high. Positive sentiment and mentions are up due to the acquisition news and recent highs. ### About Tourmaline Bio, Inc. Common Stock Tourmaline Bio, Inc. Common Stock (TRML) is a stock associated with a company being acquired by Novartis. Tourmaline Bio, Inc. Common Stock uses the ticker $TRML for trading. Listed in the [Stocks](/list/stocks) and category. ### Insights [#](/topic/$trml/insights) - Tourmaline Bio, Inc. Common Stock Price hit a 52-Week high of XXXXX for the hour - Tourmaline Bio, Inc. Common Stock Price hit an all time of XXXXX for the hour ### Price: $XXXXX [#](/topic/$trml/close) ---  [Price 24-Hour Time-Series Raw Data](/topic/$trml/time-series/close.tsv) The price action is driven by the acquisition news, with the stock trading near the $XX acquisition price. The recent 52-week high and positive social sentiment support this. | 24-Hour | 7-Day | 30-Day | | ------- | ----- | ------ | | -XXXX% | XXXX% | XXXX% | **1-Year High**: $XXXXX on 2025-09-29 **1-Year Low**: $XXXXX on 2025-04-10 ### AltRank: XXXXX [#](/topic/$trml/alt_rank) ---  [AltRank 24-Hour Time-Series Raw Data](/topic/$trml/time-series/alt_rank.tsv) Tourmaline Bio, Inc. Common Stock (TRML) is currently AltRank #1,462 based on combined combined social and market metrics **Daily Average**: XXXXX **1 Week**: XXXXX +1,457 **1 Month**: XXXXX -XXX **6 Months**: XXXXX +1,172 **1 Year**: XXXXX +596 **1-Year High**: XXXXX on 2025-08-07 **1-Year Low**: XX on 2024-11-09 ### Galaxy Score: XXXXX [#](/topic/$trml/galaxy_score) ---  [Galaxy Score 24-Hour Time-Series Raw Data](/topic/$trml/time-series/galaxy_score.tsv) **Current Value**: XXXXX **Daily Average**: XX **1 Week**: XX -X **1 Month**: XX +2 **6 Months**: XX -X **1 Year**: XX +3 **1-Year High**: XX on 2025-03-03 **1-Year Low**: X on 2025-07-17 ### Engagements: XXX [#](/topic/$trml/interactions) ---  [Engagements 24-Hour Time-Series Raw Data](/topic/$trml/time-series/interactions.tsv) **Current Value**: XXX **Daily Average**: XXXXX **1 Week**: XXXXX -XX% **1 Month**: XXXXXX -XX% **6 Months**: XXXXXXX +224% **1 Year**: XXXXXXXXX +73% **1-Year High**: XXXXXXX on 2025-09-09 **1-Year Low**: XX on 2025-10-19 | Social Network | X | | -------------- | - | | Engagements | XXX | ### Mentions: X [#](/topic/$trml/posts_active) ---  [Mentions 24-Hour Time-Series Raw Data](/topic/$trml/time-series/posts_active.tsv) **Current Value**: X **Daily Average**: XX **1 Month**: XX -XX% **6 Months**: XXXXX +205% **1 Year**: XXXXX +118% **1-Year High**: XXX on 2025-06-28 **1-Year Low**: X on 2025-01-30 | Social Network | X | | -------------- | - | | Mentions | XX | ### Creators: X [#](/topic/$trml/contributors_active) ---  [Creators 24-Hour Time-Series Raw Data](/topic/$trml/time-series/contributors_active.tsv) X unique social accounts have posts mentioning Tourmaline Bio, Inc. Common Stock (TRML) in the last XX hours which is down XX% from XX in the previous XX hours **Daily Average**: XX **1 Month**: XX -XX% **6 Months**: XXXXX +387% **1 Year**: XXXXX +298% **1-Year High**: XXX on 2025-06-28 **1-Year Low**: X on 2025-01-30 The most influential creators that mention Tourmaline Bio, Inc. Common Stock in the last XX hours | Creator | Rank | Followers | Posts | Engagements | | ------- | ---- | --------- | ----- | ----------- | | [@BiopharmIQ](/creator/twitter/BiopharmIQ) | X | XXXXXX | X | XXX | | [@LTbioinvestor](/creator/twitter/LTbioinvestor) | X | XXXXXX | X | XX | | [@BowTiedBiotech](/creator/twitter/BowTiedBiotech) | X | XXXXXX | X | XX | | [@seedy19tron](/creator/twitter/seedy19tron) | X | XXXXX | X | XX | | [@badinvestor99](/creator/twitter/badinvestor99) | X | XXX | X | XX | | [@WallStSai](/creator/twitter/WallStSai) | X | XXXXX | X | X | | [@fernando_c39637](/creator/twitter/fernando_c39637) | X | XX | X | X | | [@YBrady29668](/creator/twitter/YBrady29668) | X | XX | X | X | | [@Trade_Pro03](/creator/twitter/Trade_Pro03) | X | XX | X | X | | [@UtterP42232](/creator/twitter/UtterP42232) | XX | X | X | X | [View More](/list/creators/$trml/100) ### Sentiment: XX% [#](/topic/$trml/sentiment) ---  [Sentiment 24-Hour Time-Series Raw Data](/topic/$trml/time-series/sentiment.tsv) **Current Value**: XX% **Daily Average**: XX% **1 Week**: XX% -XX% **1 Month**: XX% -XX% **6 Months**: XX% +37% **1 Year**: XX% +30% **1-Year High**: XXX% on 2024-10-20 **1-Year Low**: XX% on 2025-05-03 **Most Supportive Themes** - **Acquisition by Novartis:** (60%) The acquisition of Tourmaline Bio by Novartis for $XX per share is a major positive catalyst. - **52-Week Highs and Momentum:** (25%) Posts highlight the stock reaching 52-week highs and strong pre-market momentum. **Most Critical Themes** - **Downgrades:** (15%) Some analysts have downgraded the stock, which could temper enthusiasm. Network engagement breakdown: | Network | Positive | % | Neutral | % | Negative | % | | ------- | -------- | - | ------- | - | -------- | - | | X | X | X% | XXX | XX% | X | X% | | | | | | | | | | Total | X | X% | XXX | XX% | X | X% | ### Social Dominance: XXXXXXX% [#](/topic/$trml/social_dominance) ---  [Social Dominance 24-Hour Time-Series Raw Data](/topic/$trml/time-series/social_dominance.tsv) **Current Value**: XXXXXXX% **Daily Average**: XXXXXXX% **1 Week**: XXXXXX% -XXXXXXXXXXXXXXXXXXXXXX% **1 Month**: XXXXXXX% -XXXXXXX% **6 Months**: XXXXXXX% -XXXXXXX% **1 Year**: XXXXXXX% -XXXXXXX% **1-Year High**: XXXXX% on 2024-10-24 **1-Year Low**: XXXXXX% on 2025-01-30 ### Market Dominance: XXXXXXX% [#](/topic/$trml/market_dominance) ---  [Market Dominance 24-Hour Time-Series Raw Data](/topic/$trml/time-series/market_dominance.tsv) **Current Value**: XXXXXXX% **Daily Average**: X% **1-Year High**: XXXXX% on 2025-03-31 **1-Year Low**: XXXXXXX% on 2025-02-20 ### Market Cap: $XXXXXXXXXXXXX [#](/topic/$trml/market_cap) ---  [Market Cap 24-Hour Time-Series Raw Data](/topic/$trml/time-series/market_cap.tsv) **Current Value**: $XXXXXXXXXXXXX **Daily Average**: $XXXXXXXXXXX **1 Week**: $XXXXXXXXXXXXX +$0.04% **1 Month**: $XXXXXXXXXXXXX +$0.44% **6 Months**: $XXXXXXXXXXXXX +$186% **1 Year**: $XXXXXXXXXXXXX +$70% **1-Year High**: $XXXXXXXXXXXXX on 2025-09-29 **1-Year Low**: $XXXXXXXXXXX on 2025-04-10 **Top assets mentioned** In the posts about Tourmaline Bio, Inc. Common Stock in the last XX hours [Novartis AG (NVS)](/topic/novartis) [Novartis AG (NVS)](/topic/$nvs) [Brady Corporation (BRC)](/topic/$brc) [Immunovant, Inc. Common Stock (IMVT)](/topic/$imvt) [Metsera, Inc. Common Stock (MTSR)](/topic/$mtsr) [Akropolis (AKRO)](/topic/$akro) [Teck Resources Limited (TECK)](/topic/$teck) [Roivant Sciences Ltd. Common Shares (ROIV)](/topic/$roiv) [MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX)](/topic/$mltx) **Top topics mentioned** In the posts about Tourmaline Bio, Inc. Common Stock in the last XX hours [stocks healthcare](/topic/stocks-healthcare), [novartis](/topic/novartis), [$novnsw](/topic/$novnsw), [$nvs](/topic/$nvs), [stocks technology](/topic/stocks-technology), [stocks consumer cyclical](/topic/stocks-consumer-cyclical), [$brc](/topic/$brc), [$imvt](/topic/$imvt), [$mtsr](/topic/$mtsr), [$akro](/topic/$akro), [$etnb](/topic/$etnb), [$14b](/topic/$14b), [$teck](/topic/$teck), [teck resources](/topic/teck-resources), [$roiv](/topic/$roiv), [$argx](/topic/$argx), [$mltx](/topic/$mltx), [$bpmc](/topic/$bpmc), [$pfe](/topic/$pfe), [$rapp](/topic/$rapp), [acquisition](/topic/acquisition), [has been](/topic/has-been), [investment](/topic/investment), [stocks financial services](/topic/stocks-financial-services), [coins defi](/topic/coins-defi), [$avtx](/topic/$avtx), [bitmine](/topic/bitmine), [stocks bitcoin treasuries](/topic/stocks-bitcoin-treasuries), [$mrus](/topic/$mrus), [$sats](/topic/$sats), [alibaba group](/topic/alibaba-group), [$cgem](/topic/$cgem), [$pmvp](/topic/$pmvp), [$atyr](/topic/$atyr), [$elut](/topic/$elut), [boston scientific](/topic/boston-scientific), [boston](/topic/boston), [$qmmm](/topic/$qmmm), [$nbis](/topic/$nbis), [betting](/topic/betting), [headed](/topic/headed), [johnson johnson](/topic/johnson-johnson), [$amgn](/topic/$amgn), [$slno](/topic/$slno), [$rna](/topic/$rna), [$ocul](/topic/$ocul), [$rxdx](/topic/$rxdx), [cere network](/topic/cere-network), [$dnth](/topic/$dnth), [$nktr](/topic/$nktr), [$idya](/topic/$idya), [$trvi](/topic/$trvi), [$mrk](/topic/$mrk), [$azn](/topic/$azn), [algo](/topic/algo), [nov inc](/topic/nov-inc), [stocks energy](/topic/stocks-energy), [$nov](/topic/$nov), [$aapl](/topic/$aapl), [$epr](/topic/$epr), [$nvda](/topic/$nvda), [$tern](/topic/$tern), [$tars](/topic/$tars), [$cnta](/topic/$cnta), [$dnli](/topic/$dnli), [$48share](/topic/$48share), [$194k](/topic/$194k), [$14billion](/topic/$14billion), [$ngloy](/topic/$ngloy), [stocks](/topic/stocks), [decent](/topic/decent), [$orcl](/topic/$orcl), [delta](/topic/delta), [anchor](/topic/anchor), [$maze](/topic/$maze), [drugs](/topic/drugs), [vrtx](/topic/vrtx), [$smmt](/topic/$smmt), [$xbi](/topic/$xbi), [lauren](/topic/lauren), [$sfm](/topic/$sfm), [stocks crypto treasuries](/topic/stocks-crypto-treasuries), [$oklo](/topic/$oklo), [$ng](/topic/$ng), [chris jones](/topic/chris-jones), [$stok](/topic/$stok), [$ryzb](/topic/$ryzb) ### Top Social Posts [#](/topic/$trml/posts) --- Top posts by engagements in the last XX hours *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "$akro nice . 3rd BO in the last couple of weeks ( after $mrus and $trml ) in my quality biotech portfolio" [X Link](https://x.com/LTbioinvestor/status/1976243538959462845) [@LTbioinvestor](/creator/x/LTbioinvestor) 2025-10-09T11:09Z 17.1K followers, 4151 engagements "@a_a_free Dude its insane from Avoros last filing: Actual rumours: $slno $mltx $rna $ocul Buyouts: $bpmc $trml $etnb Deals: $glue Bezgod for a reason" [X Link](https://x.com/seedy19tron/status/1968576044744462681) [@seedy19tron](/creator/x/seedy19tron) 2025-09-18T07:21Z 8704 followers, 3500 engagements "$ROIV appears to be finally starting to get some credit here for its pipeline and robust balance sheet. The yawning gap in valuations with $ARGX is a reminder of the potential" [X Link](https://x.com/MBbiotech/status/1965733478974259416) [@MBbiotech](/creator/x/MBbiotech) 2025-09-10T11:05Z 4242 followers, 1540 engagements "Stocks I watch up at least X% on =1.5xAvgVol for the day (==IPO in last X yrs): $TRML: 20.2xAV; +57.9% (Bio/Pharm)== $TECK: 7xAV; +11.3% (Materials) $NBIS: 5.9xAV; +49.4% (Software:Infrastructure) $KC: 3.9xAV; +14.6% (Tech Services:Infrastructure)== $DNTH: 3.2xAV; +11.9% (Bio/Pharm) $QMMM: 3xAV; +1736.7% (Telcom/Media)== $MAX: 2.9xAV; +5.1% (Leisure:Media)== $WB: 2.8xAV; +6.5% (Leisure:Media) $ALNY: 2.7xAV; +6% (Bio/Pharm) $ABUS: 2.7xAV; +5.9% (Bio/Pharm) $CNTA: 2.7xAV; +15.6% (Bio/Pharm)== $TRVI: 2.6xAV; +10.8% (Bio/Pharm) $ADUR: 2.6xAV; +11.6% (Industrial:Environmental)== $RZLV: 2.4xAV;" [X Link](https://x.com/Brad_E_Schulz/status/1965565738166747193) [@Brad_E_Schulz](/creator/x/Brad_E_Schulz) 2025-09-09T23:59Z 17.6K followers, 1147 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Novartis to acquire Tourmaline Bio for $XX per share, causing the stock to surge to a 52-week high. Positive sentiment and mentions are up due to the acquisition news and recent highs.
Tourmaline Bio, Inc. Common Stock (TRML) is a stock associated with a company being acquired by Novartis.
Tourmaline Bio, Inc. Common Stock uses the ticker $TRML for trading. Listed in the Stocks and category.
Price 24-Hour Time-Series Raw Data
The price action is driven by the acquisition news, with the stock trading near the $XX acquisition price. The recent 52-week high and positive social sentiment support this.
24-Hour | 7-Day | 30-Day |
---|---|---|
-XXXX% | XXXX% | XXXX% |
1-Year High: $XXXXX on 2025-09-29
1-Year Low: $XXXXX on 2025-04-10
AltRank 24-Hour Time-Series Raw Data
Tourmaline Bio, Inc. Common Stock (TRML) is currently AltRank #1,462 based on combined combined social and market metrics
Daily Average: XXXXX
1 Week: XXXXX +1,457
1 Month: XXXXX -XXX
6 Months: XXXXX +1,172
1 Year: XXXXX +596
1-Year High: XXXXX on 2025-08-07
1-Year Low: XX on 2024-11-09
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
1 Week: XX -X
1 Month: XX +2
6 Months: XX -X
1 Year: XX +3
1-Year High: XX on 2025-03-03
1-Year Low: X on 2025-07-17
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXXXX
1 Week: XXXXX -XX%
1 Month: XXXXXX -XX%
6 Months: XXXXXXX +224%
1 Year: XXXXXXXXX +73%
1-Year High: XXXXXXX on 2025-09-09
1-Year Low: XX on 2025-10-19
Social Network | X |
---|---|
Engagements | XXX |
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: XX
1 Month: XX -XX%
6 Months: XXXXX +205%
1 Year: XXXXX +118%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-01-30
Social Network | X |
---|---|
Mentions | XX |
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning Tourmaline Bio, Inc. Common Stock (TRML) in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX
1 Month: XX -XX%
6 Months: XXXXX +387%
1 Year: XXXXX +298%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-01-30
The most influential creators that mention Tourmaline Bio, Inc. Common Stock in the last XX hours
Creator | Rank | Followers | Posts | Engagements |
---|---|---|---|---|
@BiopharmIQ | X | XXXXXX | X | XXX |
@LTbioinvestor | X | XXXXXX | X | XX |
@BowTiedBiotech | X | XXXXXX | X | XX |
@seedy19tron | X | XXXXX | X | XX |
@badinvestor99 | X | XXX | X | XX |
@WallStSai | X | XXXXX | X | X |
@fernando_c39637 | X | XX | X | X |
@YBrady29668 | X | XX | X | X |
@Trade_Pro03 | X | XX | X | X |
@UtterP42232 | XX | X | X | X |
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% -XX%
1 Month: XX% -XX%
6 Months: XX% +37%
1 Year: XX% +30%
1-Year High: XXX% on 2024-10-20
1-Year Low: XX% on 2025-05-03
Most Supportive Themes
Most Critical Themes
Network engagement breakdown:
Network | Positive | % | Neutral | % | Negative | % |
---|---|---|---|---|---|---|
X | X | X% | XXX | XX% | X | X% |
Total | X | X% | XXX | XX% | X | X% |
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: XXXXXXX%
1 Week: XXXXXX% -XXXXXXXXXXXXXXXXXXXXXX%
1 Month: XXXXXXX% -XXXXXXX%
6 Months: XXXXXXX% -XXXXXXX%
1 Year: XXXXXXX% -XXXXXXX%
1-Year High: XXXXX% on 2024-10-24
1-Year Low: XXXXXX% on 2025-01-30
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-03-31
1-Year Low: XXXXXXX% on 2025-02-20
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXX
1 Week: $XXXXXXXXXXXXX +$0.04%
1 Month: $XXXXXXXXXXXXX +$0.44%
6 Months: $XXXXXXXXXXXXX +$186%
1 Year: $XXXXXXXXXXXXX +$70%
1-Year High: $XXXXXXXXXXXXX on 2025-09-29
1-Year Low: $XXXXXXXXXXX on 2025-04-10
Top assets mentioned In the posts about Tourmaline Bio, Inc. Common Stock in the last XX hours
Novartis AG (NVS) Novartis AG (NVS) Brady Corporation (BRC) Immunovant, Inc. Common Stock (IMVT) Metsera, Inc. Common Stock (MTSR) Akropolis (AKRO) Teck Resources Limited (TECK) Roivant Sciences Ltd. Common Shares (ROIV) MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX)
Top topics mentioned In the posts about Tourmaline Bio, Inc. Common Stock in the last XX hours
stocks healthcare, novartis, $novnsw, $nvs, stocks technology, stocks consumer cyclical, $brc, $imvt, $mtsr, $akro, $etnb, $14b, $teck, teck resources, $roiv, $argx, $mltx, $bpmc, $pfe, $rapp, acquisition, has been, investment, stocks financial services, coins defi, $avtx, bitmine, stocks bitcoin treasuries, $mrus, $sats, alibaba group, $cgem, $pmvp, $atyr, $elut, boston scientific, boston, $qmmm, $nbis, betting, headed, johnson johnson, $amgn, $slno, $rna, $ocul, $rxdx, cere network, $dnth, $nktr, $idya, $trvi, $mrk, $azn, algo, nov inc, stocks energy, $nov, $aapl, $epr, $nvda, $tern, $tars, $cnta, $dnli, $48share, $194k, $14billion, $ngloy, stocks, decent, $orcl, delta, anchor, $maze, drugs, vrtx, $smmt, $xbi, lauren, $sfm, stocks crypto treasuries, $oklo, $ng, chris jones, $stok, $ryzb
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$akro nice . 3rd BO in the last couple of weeks ( after $mrus and $trml ) in my quality biotech portfolio"
X Link @LTbioinvestor 2025-10-09T11:09Z 17.1K followers, 4151 engagements
"@a_a_free Dude its insane from Avoros last filing: Actual rumours: $slno $mltx $rna $ocul Buyouts: $bpmc $trml $etnb Deals: $glue Bezgod for a reason"
X Link @seedy19tron 2025-09-18T07:21Z 8704 followers, 3500 engagements
"$ROIV appears to be finally starting to get some credit here for its pipeline and robust balance sheet. The yawning gap in valuations with $ARGX is a reminder of the potential"
X Link @MBbiotech 2025-09-10T11:05Z 4242 followers, 1540 engagements
"Stocks I watch up at least X% on =1.5xAvgVol for the day (==IPO in last X yrs): $TRML: 20.2xAV; +57.9% (Bio/Pharm)== $TECK: 7xAV; +11.3% (Materials) $NBIS: 5.9xAV; +49.4% (Software:Infrastructure) $KC: 3.9xAV; +14.6% (Tech Services:Infrastructure)== $DNTH: 3.2xAV; +11.9% (Bio/Pharm) $QMMM: 3xAV; +1736.7% (Telcom/Media)== $MAX: 2.9xAV; +5.1% (Leisure:Media)== $WB: 2.8xAV; +6.5% (Leisure:Media) $ALNY: 2.7xAV; +6% (Bio/Pharm) $ABUS: 2.7xAV; +5.9% (Bio/Pharm) $CNTA: 2.7xAV; +15.6% (Bio/Pharm)== $TRVI: 2.6xAV; +10.8% (Bio/Pharm) $ADUR: 2.6xAV; +11.6% (Industrial:Environmental)== $RZLV: 2.4xAV;"
X Link @Brad_E_Schulz 2025-09-09T23:59Z 17.6K followers, 1147 engagements
/topic/$trml